Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dillard’s, Inc. (DDS): Should You Avoid This Retail Enigma?

Page 1 of 2

On the surface, Dillard’s, Inc. (NYSE:DDS) seems like an attractive value stock. Shares trade for a little less than 13 times trailing EPS of $6.32, with better than 10% earnings growth expected for 2013. Moreover, same-store sales have increased for 10 consecutive quarters, driving solid earnings growth over the past few years.

Dillard's, Inc. (NYSE:DDS)Despite all these favorable trends, I would be cautious when investing in Dillard’s, Inc. (NYSE:DDS). The company has been extremely secretive recently, which makes it very difficult to evaluate the strength of its business. Historically, most department stores reported same-store sales on a monthly basis, but Dillard’s, Inc. (NYSE:DDS) stopped doing so in early 2012 (many other chains have followed its example). Moreover, Dillard’s, Inc. (NYSE:DDS) does not host a quarterly earnings conference call, which means that the public knows very little about recent business trends or management’s strategy going forward. Given the lack of available information, investors should consider approaching Dillard’s, Inc. (NYSE:DDS) from a skeptical perspective.

Sales growth… for now
For the fourth quarter, comparable-store sales grew by 3% at Dillard’s. This was better than downmarket rivals: For example, Kohl’s Corporation (NYSE:KSS) posted a 1.9% comparable-store sales gain for the quarter. On the other hand, it represented a deceleration from Dillard’s 5% gain in the third quarter, and also trailed close competitor Macy’s, Inc. (NYSE:M) (where same-store sales increased by 3.9%) and higher-end chains like Nordstrom, Inc. (NYSE:JWN) (which achieved a 6.3% gain). In other words, while Dillard’s posted good sales, it trailed some competitors and saw sales growth slow somewhat compared to the prior quarter.

Unfortunately, Dillard’s, Inc. (NYSE:DDS) did not provide much commentary to illuminate these results. The earnings release features a brief statement from CEO William T. Dillard II that reiterates some of the company’s financial results for the quarter and full year, and Dillard states that he is “excited about the future.” The only other “guidance” provided was estimates of D&A expense, rental expense, interest, and capital expenditures. Whereas competitors at least took a stab at projecting sales and earnings trends for 2013, Dillard’s did no such thing.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!